The FDA has set a Prescription Drug User Fee Act (PDUFA), or target action, date of May 26 ... Certain von Hippel-Lindau (VHL) disease-associated tumors WELIREG (belzutifan) is indicated for the ...

Rahway, New Jersey Tuesday, January 28, 2025, 10:00 Hrs [IST] ...

Researchers at the University of Basel are able to test in parallel the effects of over 1,500 active substances on cell ...

The question of putative mechanisms of action continues to haunt psychopharmacology. Put simply, we know these drugs work, but we have very little idea how. We make guesses based on the ...

The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date set for May 26, 2025.

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

Structural and cellular assays and molecular dynamics simulations reveal the mechanism of action of γ-glutamyl carboxylase, which involves cholesterol and vitamin K. Protein kinase R-like ...

Sometimes you just want to watch someone kick butt. That's where the best action movies come in, with their endless supply of fights, chases, and explosions. No genre packs more punches — and ...

In a randomized trial, recurrence was higher after superficial curettage (SC) plus imiquimod cream than surgical excision (SE) in patients with nodular basal cell carcinoma (nBCC). At 5 years ...

In final draft guidance due to be finalised before the end of the month, Welireg (belzutifan) has been recommended as an option for treating adults with von Hippel-Lindau (VHL) disease ...